2型糖尿病缓解:来自美国生活方式医学会的立场声明(2020)和专家共识(2022)——解读与思考  

Remission of type 2 diabetes mellitus:position statement from the American Society of Lifestyle Medicine(2020)and Expert Consensus(2022)—interpretation and reflections

作　　者：杨雪[1] 何志伟 陈煜[1] 陈国芳[1] 刘超[1] Yang Xue;He Zhiwei;Chen Yu;Chen Guofang;Liu Chao(Department of Endocrinology,Affiliated Hospital of Integrated Traditional Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Nanjing 210028,China)

机构地区：[1]南京中医药大学附属中西医结合医院内分泌科,南京210028

出　　处：《国际内分泌代谢杂志》2023年第2期195-198,共4页International Journal of Endocrinology and Metabolism

基　　金：江苏省第十六批"六大人才高峰"项目(WSN-035)。

摘　　要：随着医学技术的进步和多年的探索,缓解2型糖尿病的研究取得了丰硕的成果。但此前,国际上尚无相关权威指南。2020年,美国生活方式医学会发布的立场声明首次对缓解2型糖尿病的相关现状及建议进行了阐述,并明确指出,通过适当强度的生活方式干预缓解2型糖尿病应该为所有2型糖尿病患者治疗的首要目标;2022年,美国生活方式医学会再次发布专家共识,推荐饮食疗法作为缓解2型糖尿病的首要手段,并就饮食疗法相关事项进行了详细推荐。Thanks to the advances in medical technology and years of exploration,a huge progress has been made in terms of remission of diabetes.However,there is no relevant authoritative guideline before.The position statement issued by the American College of Lifestyle Medicine in 2020 recommended that remission should be the first clinical goal in T2DM treatment using properly dosed intensive lifestyle interventions.In 2022,the American College of Lifestyle Medicine again issued an expert consensus,recommending dietary therapy as the primary means of alleviating type 2 diabetes mellitus,with detailed recommendations on dietary therapy-related matters.

关 键 词：2型糖尿病 缓解 生活方式医学 立场声明 专家共识 解读 

分 类 号：R587.1[医药卫生—内分泌]